Additionally, UCB CAR-T cells express exhaustion markers like PD1, LAG3, or TIM3 on significantly lower levels compared to allogeneic PB-derived CAR, which translates into the capability of longer persistence in vivo and decreased potential risk of GVHD (125). The gene discussed is HAVCR2; the disease is graft versus host disease.